Author: Watson S. Young A.H.
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.2, Iss.4, 2001-04, pp. : 601-612
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New options with olanzapine in bipolar disorders
Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. :
Challenges and Advances in Gene Therapy Approaches for Neurodegenerative Disorders
Current Gene Therapy, Vol. 17, Iss. 3, 2017-12 ,pp. :
Oxcarbazepine as adjunctive therapy is effective in the treatment of patients with bipolar disorders
Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. :
Inflammatory Disorders and Atherosclerosis: New Therapeutic Approaches
Current Pharmaceutical Design, Vol. 17, Iss. 37, 2011-12 ,pp. :